10 key points for addressing cholesterol

Lipid-lowering therapy for primary prevention of atherosclerotic cardiovascular disease (ASCVD) can be a complex decision, according to a leading US cardiologist.

But in most cases, the decision should be about risk reduction, not cholesterol levels, says Dr Harlan Krumholz, a professor of medicine (cardiology) at Yale.